Lion Street Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lion Street Advisors's PFE Position: Q3 2025 in Review
Lion Street Advisors increased its Pfizer (PFE) stake by 2.1% in Q3 2025, buying an estimated $5.41K and bringing the position to 10,600 shares worth $464K. The position accounts for 0.16% of the portfolio, ranked #124.
Lion Street Advisors first reported a position in PFE in Q1 2020 and has held it in 18 quarters since. 2,817 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Lion Street Advisors held 10,600 shares of Pfizer worth $464K as of Q3 2025.
- Lion Street Advisors bought 219 Pfizer shares in Q3 2025, an estimated $5.41K.
- Pfizer made up 0.16% of Lion Street Advisors's portfolio in Q3 2025, its #124 holding.
- Lion Street Advisors first reported a position in Pfizer in Q1 2020 and has held it in 18 quarters since.
- 2,817 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Lion Street Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.